Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06612190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation on Visual Outcome of TMS

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years 11 months later Oct 2025 → Oct 2030
See other at-risk trials from Evidence Based Cataract Study Group

Record History

  1. Primary completion pushed from Oct 2025 to Oct 2030v2 Show 4 more changesShow less
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Study completion pushed from Oct 2027 to Oct 2035
    • Start date changed from estimate of Oct 2024 to Sep 15, 2024
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients with visual impairment. The main question it aims to answer is: • Does TMS improve the visual outcome in patients who suffer from visual impairment? Researchers will compare TMS to the control group who will not receive effective TMS treatment) to see if TMS works to improve the visual outcomes of the patients. Participants will * Undergo TMS treatment or no effective TMS for consecutive 5 days. * Visit the clinic once every 2 weeks for checkups and tests.
Trial Details
NCT Number NCT06612190
Lead Sponsor Evidence Based Cataract Study Group
Conditions
(from sponsor)		 Visual Impairment
Related terms Vision Disorders
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov